Facebook Instagram Linkedin Twitter
  • Home
  • Podcasts
  • Video
  • Contact Us
  • Partnership
Search
Logo
Logo
Logo
Search
  • Home
  • Podcasts
  • Video
  • Contact Us
  • Partnership
Logo
Search
  • Home
  • Podcasts
  • Video
  • Contact Us
  • Partnership

ESSILOR® REDEFINES ANTI-REFLECTIVE PERFORMANCE WITH CRIZAL®’S LEAST VISIBLE COATING*1

Dr. Darryl Glover - April 6, 2026

EssilorLuxottica and Meta Expand AI Glasses Portfolio with Ray-Ban Meta Optics Styles 

Transitions Optical Announces Call for Education Grant Applications

In New Research from The Vision Council, Eyecare Providers Adapt to Tariffs and Inflation, Report Stronger Second Half of 2025

Transitions® Opens 2026 With Updated Certification Program

EYECON Returns to New York City March 2026 — A Unique Show Platform  Honoring...

Drs. Glover & Lyerly - October 27, 2025

LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States

Drs. Glover & Lyerly - September 30, 2025

Essilor Stellest is the first and only FDA market authorized spectacle lens in the...

Drs. Glover & Lyerly - September 25, 2025

LENZ Therapeutics Announces US FDA Approval of VIZZâ„¢ for the Treatment of Presbyopia

Drs. Glover & Lyerly - August 2, 2025

Oakley has officially named Travis Scott as their first-ever Chief Visionary

Dr. Darryl Glover - June 25, 2025

Transitions Announces Winners of its Optical Advancement Educational Grants

Dr. Darryl Glover - June 3, 2025

Transitions ® Certification Program Updated with New Education Opportunities

Dr. Darryl Glover - May 1, 2025

New England College of Optometry Announces 2025 Honorary Degree Recipient, Award Winners, and Valedictorian

Drs. Glover & Lyerly - May 1, 2025

The Vision Council Unites 150 Industry Leaders at 2025 Lab Leadership Forum and Emerging...

Dr. Darryl Glover - April 30, 2025

New England College of Optometry Unveils Bold Five-Year Strategic Plan: The Future InSight

Dr. Darryl Glover - April 23, 2025
123...17Page 1 of 17
  • About Us
  • Partnership Opportunities
  • Subscribe
© Copyright 2023. All Rights Reserved, Defocus Media.